HOOMAN AZMI: Open Payments
NPI 1588971618 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 72 payments from 21 companies in 2025. Trend: 2023 $1,773 · 2024 $1,194 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $212 |
| Novo Nordisk Inc | 10 | $183 |
| Lilly USA, LLC | 8 | $167 |
| Amgen Inc. | 4 | $87 |
| SCILEX PHARMACEUTICALS INC. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| Lundbeck LLC | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| Abbott Laboratories | 1 | $65 |
Products named: ELIQUIS, MOUNJARO, Ozempic, NURTEC ODT, ZTLido, TRINTELLIX, GEMTESA, INFINITY.
Industry payments across MD — which companies pay providers there.
